| Acquired by | Covidien |
| Date | 3/12 |
| Website | superdimension.com |
| Blog | superdimension.co... |
| Category | BioTech |
| Phone | 763-210-4000 |
| info.us@superdime... | |
| Employees | |
| Founded | 1995 |
| TOTAL | $35.8M |
| FUNDING TOTAL | $35.8M |
| Venture Round, 9/10 Medica Venture Partners OrbiMed Advisors Oxford Bioscience Partners Pitango Venture Capital | $24.8M |
| Venture Round, 9/11 Covidien Ventures | $11M |
SuperDimension is a privately-held medical device company that develops and markets minimally-invasive pulmonology devices that enable the diagnosis and potentially the treatment of distal lung disease. Our product line, the i·LogicTM System, includes both capital equipment and disposables, addressing a total available market of more than 8 million patients.
Driven by our mission, “To be the world leader in the diagnosis and treatment of distal lung disease,” we are focused on extending the capabilities of traditional bronchoscopy tools to help diagnose previously inaccessible lung lesions at an earlier stage when they may be easier to treat.